Research programme: progesterone - Encore Therapeutics
Alternative Names: ETI-411; PE/ProgesteroneLatest Information Update: 25 Dec 2021
At a glance
- Originator Encore Therapeutics
- Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules; Steroids
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Brain injuries; Stroke
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for research development in Brain injuries in USA (IV)
- 04 Nov 2017 No recent reports of development identified for research development in Stroke in USA (IV)
- 06 Apr 2011 Research is ongoing in USA